![Headshot of Noel Brewer](https://unclineberger.org/wp-content/uploads/sites/867/2021/10/Noel-Brewer-feature-600x400.jpg)
March 1, 2022
Public health leads researcher to communication advances
Noel Brewer, PhD, has always been fascinated by health behavior. Brewer's research focuses on vaccination, smoking and health screening.
March 1, 2022
Noel Brewer, PhD, has always been fascinated by health behavior. Brewer's research focuses on vaccination, smoking and health screening.
February 24, 2022
Greg Wang, PhD, and colleagues have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during cancer development.
February 10, 2022
Paul Dayton, PhD, the William R. Kenan Distinguished Professor of Biomedical Engineering, has been named chair of the Joint UNC-NCSU Department of Biomedical Engineering.
February 7, 2022
Blossom Damania, PhD, and Dirk Dittmer, PhD, are being recognized individually for their expertise in cancer virology and global oncology, and their service to the university and state.
January 31, 2022
Four UNC Lineberger members have been elected 2021 fellows of the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.
January 26, 2022
In a laboratory study, UNC Lineberger researchers report a novel combination of two drugs delivered in a nanoparticle formulation may suggest an approach for a less toxic treatment for medulloblastoma, the most common pediatric brain cancer.
January 26, 2022
Marc Bjurlin, DO, MSc, FACOS, specializes in minimally invasive techniques in cancer surgery and brings his expertise to the single port robotic surgery program.
January 19, 2022
Ashley Leak Bryant, PhD, RN, OCN, FAAN, joins Bernard Weissman, PhD, and Jen Jen Yeh, MD, who lead as co-associate directors of Cancer Research Training Education Coordination (CRTEC).
January 18, 2022
At the recent San Antonio Breast Cancer Symposium, Lisa A. Carey, MD, ScM, FASCO, presented a plenary talk on the latest developments in triple negative breast cancer.
January 18, 2022
Pengda Liu, PhD, was awarded the grant to support his research targeting ATR/SPOP signaling to overcome chemotherapy resistance in Ewing sarcoma, a bone cancer that occurs mainly in children.